Effect of biotechnological cytochromec on the early postocclusion and reperfusion arrhythmias

Biotechnological cytochromec showed a lower antiarrhythmic activity in cats with acute occlusion and reperfusion arrhythmias than trimecaine, verapamil, and quaternidine but a higher activity than anapriline. Under experimental conditions, cytochromec potentiated the antiarrhythmic effect of trimeca...

Full description

Saved in:
Bibliographic Details
Published in:Bulletin of experimental biology and medicine 1999-01, Vol.127 (1), p.80-82
Main Authors: Balykova, L. A., Balashov, V. P., Kostin, Ya. V., Sernov, L. N.
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Biotechnological cytochromec showed a lower antiarrhythmic activity in cats with acute occlusion and reperfusion arrhythmias than trimecaine, verapamil, and quaternidine but a higher activity than anapriline. Under experimental conditions, cytochromec potentiated the antiarrhythmic effect of trimecaine and quaternidine.[PUBLICATION ABSTRACT]
ISSN:0007-4888
1573-8221
DOI:10.1007/BF02432808